Found: 21
Select item for more details and to access through your institution.
In vitro evaluation of the reductive carbonyl idarubicin metabolism to evaluate inhibitors of the formation of cardiotoxic idarubicinol via carbonyl and aldo–keto reductases.
- Published in:
- Archives of Toxicology, 2024, v. 98, n. 3, p. 807, doi. 10.1007/s00204-023-03661-7
- By:
- Publication type:
- Article
Comprehensive in vitro analysis evaluating the variable drug–drug interaction risk of rifampicin compared to rifabutin.
- Published in:
- Archives of Toxicology, 2023, v. 97, n. 8, p. 2219, doi. 10.1007/s00204-023-03531-2
- By:
- Publication type:
- Article
Intact plasma quantification of the large therapeutic lipopeptide bulevirtide.
- Published in:
- Analytical & Bioanalytical Chemistry, 2021, v. 413, n. 22, p. 5645, doi. 10.1007/s00216-021-03384-7
- By:
- Publication type:
- Article
An Underestimated Factor: The Extent of Cross-Reactions Modifying APIs in Surface-Modified Liposomal Preparations Caused by Comprised Activated Lipids.
- Published in:
- Molecules, 2020, v. 25, n. 19, p. 4436, doi. 10.3390/molecules25194436
- By:
- Publication type:
- Article
A Nanocarrier Approach for Oral Peptide Delivery: Evaluation of Cell‐Penetrating‐Peptide‐Modified Liposomal Formulations in Dogs.
- Published in:
- Advanced Therapeutics, 2023, v. 6, n. 10, p. 1, doi. 10.1002/adtp.202300021
- By:
- Publication type:
- Article
Overcoming the Mucosal Barrier: Tetraether Lipid‐Stabilized Liposomal Nanocarriers Decorated with Cell‐Penetrating Peptides Enable Oral Delivery of Vancomycin.
- Published in:
- Advanced Therapeutics, 2021, v. 4, n. 4, p. 1, doi. 10.1002/adtp.202000247
- By:
- Publication type:
- Article
High treatment efficacy by dual targeting of Burkitt's lymphoma xenografted mice with a Lu-based CD22-specific radioimmunoconjugate and rituximab.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 3, p. 489, doi. 10.1007/s00259-015-3175-6
- By:
- Publication type:
- Article
Radiolabeling Strategies for Tumor-Targeting Proteinaceous Drugs.
- Published in:
- Molecules, 2014, v. 19, n. 2, p. 2135, doi. 10.3390/molecules19022135
- By:
- Publication type:
- Article
PET/CT Imaging of NSCLC with a α<sub>v</sub>β<sub>6</sub> Integrin-Targeting Peptide.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effect of Tacrolimus Formulation (Prolonged‐Release vs Immediate‐Release) on Its Susceptibility to Drug‐Drug Interactions with St. John's Wort.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 3, p. 297, doi. 10.1002/cpdd.1364
- By:
- Publication type:
- Article
Effect of Pantoprazole on the Absorption of Hydroxychloroquinea A Randomized Drug‐Drug Interaction Trial in Healthy Adults.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 2, p. 285, doi. 10.1002/cpdd.999
- By:
- Publication type:
- Article
Bioanalysis of the Ex Vivo Labile PACE4 Inhibitory Peptide Ac-[d-Leu]LLLRVK-Amba in Whole Blood Using Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Quantification.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 12, p. 2745, doi. 10.3390/pharmaceutics15122745
- By:
- Publication type:
- Article
Evaluation of PepT1 (SLC15A1) Substrate Characteristics of Therapeutic Cyclic Peptides.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 8, p. 1610, doi. 10.3390/pharmaceutics14081610
- By:
- Publication type:
- Article
Simultaneous Quantification and Pharmacokinetic Characterization of Doxapram and 2-Ketodoxapram in Porcine Plasma and Brain Tissue.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 4, p. N.PAG, doi. 10.3390/pharmaceutics14040762
- By:
- Publication type:
- Article
Investigating the Central Nervous System Disposition of Actinomycin D: Implementation and Evaluation of Cerebral Microdialysis and Brain Tissue Measurements Supported by UPLC-MS/MS Quantification.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 9, p. 1498, doi. 10.3390/pharmaceutics13091498
- By:
- Publication type:
- Article
Rapid and Sensitive Quantification of Intracellular Glycyl-Sarcosine for Semi-High-Throughput Screening for Inhibitors of PEPT-1.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 7, p. 1019, doi. 10.3390/pharmaceutics13071019
- By:
- Publication type:
- Article
Comparison of the RGD Motif–Containing α<sub>v</sub>β<sub>6</sub> Integrin–Binding Peptides SFLAP3 and SFITGv6 for Diagnostic Application in HNSCC.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 11, p. 1679, doi. 10.2967/jnumed.118.210013
- By:
- Publication type:
- Article
Extracellular Vesicles as Surrogates for the Regulation of the Drug Transporters ABCC2 (MRP2) and ABCG2 (BCRP).
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 7, p. 4118, doi. 10.3390/ijms25074118
- By:
- Publication type:
- Article
Correction: Bay et al. Functional Characterization of the Solute Carrier LAT-1 (SLC7A5/SLC3A2) in Human Brain Capillary Endothelial Cells with Rapid UPLC-MS/MS Quantification of Intracellular Isotopically Labelled L-Leucine. Int. J. Mol. Sci. 2022, 23 , 3637
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Metabolic Effect of Blocking Sodium-Taurocholate Co-Transporting Polypeptide in Hypercholesterolemic Humans with a Twelve-Week Course of Bulevirtide—An Exploratory Phase I Clinical Trial.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 15924, doi. 10.3390/ijms232415924
- By:
- Publication type:
- Article
Functional Characterization of the Solute Carrier LAT-1 (SLC7A5/SLC2A3) in Human Brain Capillary Endothelial Cells with Rapid UPLC-MS/MS Quantification of Intracellular Isotopically Labelled L-Leucine.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 7, p. 3637, doi. 10.3390/ijms23073637
- By:
- Publication type:
- Article